Existen ciertas limitaciones propias del diseño del estudio, sin embargo los resultados son similares a otros trabajos. Este estudio demuestra que podemos identificar individuos con un alto riesgo cardiovascular con parámetros sencillos, baratos y fáciles de interpretar. Esto tiene un gran valor en nuestro medio ya que la mayoría de estos enfermos están en cuidados primarios de salud.
Bibliografía 1. Haffner SM, Lehto S, Ronnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in non diabetic subjects with or without prior myocardial infarction. N Engl J Med 1998;339:229-234. 2. Mukamal KJ, Nesto RW, Cohen MC, et al. Impact of diabetes on long-term survival after acute myocardial infarction : comparability of risk with prior myocardial infarction. Diabetes care 2001;24: 14221427. 3. The DECODE study group . Glucose tolerance and mortality: comparison of WHO and american diabetic association diagnostic criteria. The Lancet 1999;354:617-621. 4. The DECODE study group. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases ? Diabetes care 2003;26:688-696.
Revista de la ALAD
V1 Nº1
5. Diabetes Control and Complications Trial Research group.The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986.
42
6. UKPDS Group.Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-853. 7. Moghissi ES, Korytkowski M, et al. American association of clinical
8. endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care 2009;32:1119-1131. 9. Cáceres N, De Cáceres M. Hiperglucemia en el paciente hospitalizado. ¿Se debe ser estricto en el control de la glucemia? Endocrinología, Diabetes y Metabolismo 2009; 4: 17-22. 10. Norhammar A, Tenerz A, Nilsson G, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus : a prospective study Lancet 2002;359:21402144. 11. Wallander M, Malmberg K, Norhammar A, et al. Oral glucose tolerance test: a reliable tool for early detection of glucose anormalities in patients with acute myocardial infarction in clinical practice. Diabetes care 2008;31:36-38. 12. Mozaffarian D, Marfisi RM, Levantesi G, et al. Incidence of new onset diabetes and impaired fastin glucose in patients with recent myocardial infarction and the effect of clinical and lifestyle risk factors. Lancet 2007;370:667-675. 13. Zarich SW, Nesto RW. Implications and treatment of acute hyperglycemia in the setting of acute myocardial infarction. Circulation 2007;115:e436-e439. 14. Action to control cardiovascular risk in diabetes study group. Gerstein HC, Miller ME, Byington RP, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-2559. 15. ADVANCE collaborative group, Patel A, MacMahon S, Chalmers J ,et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358:2560-2572. 16. Duckworth W, Abraira C, Moritz T, et al. Intensive glucose control and complications in american veterans with type 2 diabetes . N Engl J Med 2008;360:129-139. 17. Skyler JS, Bergenstal R, Bonow RO , et al. Intensive glycemic control and the prevention of cardiovascu-